Stay updated on Avelumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avelumab in NSCLC Clinical Trial page.

Latest updates to the Avelumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check9 days agoChange DetectedAn NIH transition notice was added, linking to updates and FAQs and explaining that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference0.6%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check23 days agoChange DetectedThe footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check44 days agoChange Detected- The history now shows a new revision entry (v3.7.0) and removes the previous revision entry (v3.6.6), reflecting an update to the study record's version history.SummaryDifference0.1%

- Check65 days agoChange DetectedThe history note now shows Revision: v3.6.6 instead of v3.6.5, reflecting a small system update to the page's versioning information.SummaryDifference0.1%

Stay in the know with updates to Avelumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in NSCLC Clinical Trial page.